Elzanaty, K.A.; Omran, G.A.; Elmahallawy, E.K.; Albrakati, A.; Saleh, A.A.; Dahran, N.; Alhegaili, A.S.; Salahuddin, A.; Abd-El-Azim, H.; Noreldin, A.;
et al. Design and Optimization of Sesamol Nanosuspensions to Potentiate the Anti-Tumor Activity of Epirubicin against Ehrlich Solid Carcinoma-Bearing Mice. Pharmaceutics 2024, 16, 937.
https://doi.org/10.3390/pharmaceutics16070937
AMA Style
Elzanaty KA, Omran GA, Elmahallawy EK, Albrakati A, Saleh AA, Dahran N, Alhegaili AS, Salahuddin A, Abd-El-Azim H, Noreldin A,
et al. Design and Optimization of Sesamol Nanosuspensions to Potentiate the Anti-Tumor Activity of Epirubicin against Ehrlich Solid Carcinoma-Bearing Mice. Pharmaceutics. 2024; 16(7):937.
https://doi.org/10.3390/pharmaceutics16070937
Chicago/Turabian Style
Elzanaty, Kholoud A., Gamal A. Omran, Ehab Kotb Elmahallawy, Ashraf Albrakati, Ayman A. Saleh, Naief Dahran, Alaa S. Alhegaili, Ahmad Salahuddin, Heba Abd-El-Azim, Ahmed Noreldin,
and et al. 2024. "Design and Optimization of Sesamol Nanosuspensions to Potentiate the Anti-Tumor Activity of Epirubicin against Ehrlich Solid Carcinoma-Bearing Mice" Pharmaceutics 16, no. 7: 937.
https://doi.org/10.3390/pharmaceutics16070937
APA Style
Elzanaty, K. A., Omran, G. A., Elmahallawy, E. K., Albrakati, A., Saleh, A. A., Dahran, N., Alhegaili, A. S., Salahuddin, A., Abd-El-Azim, H., Noreldin, A., & Okda, T. M.
(2024). Design and Optimization of Sesamol Nanosuspensions to Potentiate the Anti-Tumor Activity of Epirubicin against Ehrlich Solid Carcinoma-Bearing Mice. Pharmaceutics, 16(7), 937.
https://doi.org/10.3390/pharmaceutics16070937
